997 LENOX DRIVE, LAWRENCEVILLE, NJ
Material Definitive Agreement with Streeterville Capital - $2.5M Raised
Compensatory Programs Approved for Executive Officers at Imunon, Inc.
Reports Second Quarter 2026 Financial Results and Provides Business Update
Interim CFO Jeffrey Church Retires; New CFO Appointment Planned
Stockholders Approve Amendment to 2018 Stock Incentive Plan
Announces Up to $10 Million Cash Financing
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Q2
Q1
FY 2025
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence